A Phase I Trial of Dose Escalated Irinotecan (CPT-11) With Paclitaxel in Patients With Metastatic or Recurrent Malignancies
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Irinotecan (Primary) ; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- 11 Sep 2005 New trial record.